You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 242 No. 20, November 16, 1979 TABLE OF CONTENTS
  JAMA
  •  Online Features
  BRIEF REPORTS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Neuroblastoma, Pheochromocytoma, and Renal Cell Carcinoma

Occurrence in a Single Patient

Richard S. Fairchild, MD; Joseph L. Kyner, MD; Arlo Hermreck, MD, PhD; R. Neil Schimke, MD

JAMA. 1979;242(20):2210-2211.


Abstract

A 26-year-old woman had a neuroblastoma during infancy; an extraadrenal pheochromocytoma at age 16 years, with hepatic recurrences during the next ten years; and multifocal renal cell carcinoma. Neuroblastoma and pheochromocytoma, despite their common embryologic origin, to our knowledge have not been previously reported as separate tumors in the same patient. Although many attributes of the patient's tumors suggest a hereditary disorder, thorough investigation disclosed no evidence of heritable conditions associated with any of these tumors in the patient or her family members. Long-term observation of persons surviving after treatment of neuroblastoma will be necessary to determine whether this case represents a previously unidentified tumor predisposition or a sporadic occurrence.

(JAMA 242:2210-2211, 1979)



Author Affiliations

From the Departments of Medicine, Division of Metabolism, Endocrinology, and Genetics (Drs Fairchild, Kyner, and Schimke), and Surgery (Dr Hermreck), University of Kansas School of Medicine, Kansas City.


Footnotes

Reprint requests to 413 C Bldg, Division of Endocrinology, University of Kansas Medical Center, 39th and Rainbow Blvd, Kansas City, KN 66103 (Dr Fairchild).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

The kinesin KIF1B{beta} acts downstream from EglN3 to induce apoptosis and is a potential 1p36 tumor suppressor
Schlisio et al.
Genes Dev. 2008;22:884-893.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1979 American Medical Association. All Rights Reserved.